제19675호                                        관                   보                       2020. 1. 23.(목요일)
연번                 물질명                                              화학명칭                                   1/2군         효력기간
 73    Isopropylphenidate             propan-2-yl2-phenyl-2-(piperidin-2-yl) acetate                         2
 74    3-Fluorophenmetrazine(3-FPM)   2-(3-fluorophenyl)-3-methylmorpholine                                  2
 75    Mephenmetrazine                2-(4-methylphenyl)-3-methylmorpholine                                  2
 76    DF-MDBP                        1-[(2,2-difluorobenzo[d][1,3]dioxol-5-yl)methyl]piperazine             2
                                      methyl (E)-2-[(2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-2,3,4,6,
 77    7-Hydroxymitragynine           7,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-e           1
                                      noate
                                      methyl (E)-2-[(2S,3S)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydro-1H-i
 78    Mitragynine                    ndolo[3,2-h] quinolizin-2-yl]-3-methoxyprop-2-enoic acid methyl este         1
                                      r
 79    p-Methoxybutyrfentanyl         N-(4-methoxyphenyl)-N-[1[(2-phenylethyl)piperidin-4-yl]butanamide            1   ’19.7.31~
 80    3-HO-PCP                       3-(1-piperidin-1-ylcyclohexyl)phenol                                         2      ’22.7.30.
                                      8-bromo-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benz
 81    Flubromazolam                                                                                               2
                                      odiazepine                                                                       ’19.9.10~
                                      1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-pyrrolo[2,3-b]pyrid                  ’22.9.9.
 82    Cumyl-4CN-B7AICA                                                                                            2
                                      ine-3-carboxamide
                                      N,N-diethyl-7-methyl-4-cyclopropanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg           ’19.11.8~
 83    1cP-LSD                                                                                                     2
                                      ]-quinoline–9 -carboxamide                                                          ’22.11.7.
                                      2-(2,4-Dichlorophenyl)-N-[2-(dimethylamino)cyclohexyl]-N-methylaceta
 84    U-48,800                                                                                                    1
                                      mide
                                      5-(5-fluoropentyl)-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b
 85    5F-Cumyl-Pegaclone                                                                                          2
                                      ]indol-1-one
 86    Cyclopentylfentanyl            N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopentanecarboxamide          1
                                      4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylindene]benzenes
 87    W-18                                                                                                        2
                                      ulfonamide                                                                       ‘19.12.18
 88    Ethylnaphthidate(HDEP-2)       ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate                          2    ~’22.12.17.
 89    4-Methylmethylphenidate        methyl (2R)-2-(4-methylphenyl)-2- [(2R)-piperidin-2-yl]acetate               2
                                      (6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quino
 90    ETH-LAD                                                                                                     2
                                      line-9-carboxamide
                                      (6aR,9R)-4-acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-
 91    ALD-52                                                                                                      2
                                      fg]quinoline-9-carboxamide
 92    Mexedrone                      3-methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one                     2



◉금융위원회공고제2020-19호
「자본시장과 금융투자업에 관한 법률」 제417조제2항에 따라 다음과 같이 금융투자업 업무폐지사
실을 공고합니다.
      2020년 1월 23일
                         금융위원회 위원장

              상      호                                        폐지되는 업무                                             폐지일자
                                      「자본시장과 금융투자업에 관한 법률 시행령」                                  [별표 3]에
                                      따른 다음의 등록 업무단위
      PAAMCO Prisma, LLC                                                                                          2020.1.17.
                                              가. 5-1-1 투자자문업
                                              나. 6-1-2 투자일임업
          Janus Capital               「자본시장과 금융투자업에 관한 법률 시행령」                                  [별표 3]에
           International              따른 다음의 등록 업무단위                                                              2020.1.17.
              Limited                         가. 6-1-2 투자일임업

                                                             117